Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
CORCEPT THERAPEUTICS INC (CORT)
Standardized SEC financial data for CORCEPT THERAPEUTICS INC — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001088856 · NASDAQ · Pharmaceutical Preparations.
Gross margin
98.3%
Operating margin
5.9%
Net margin
12.9%
Revenue growth (YoY)
12.8%
Return on equity
15.2%
ROIC
4.3%
Free cash flow
$141.8M
Debt / equity
0.00×
Ratios for fiscal year 2025, standardized from SEC filings.